33927-08-1

Basic information

• Product Name: Benzoic acid, 4-(4-methoxyphenoxy)-3,5-dinitro-, methyl ester
• CAS NO: 33927-08-1
• Molecular Formula: C15H12N2O8
• Molecular Weight: 348.269
• Mol File: 33927-08-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(4-methoxyphenoxy)-3,5-dinitro-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(4-methoxyphenoxy)-3,5-dinitro-, methyl ester(33927-08-1)
• EPA Substance Registry System: Benzoic acid, 4-(4-methoxyphenoxy)-3,5-dinitro-, methyl ester(33927-08-1)

Safety Data

• Hazardous Substances Data: 33927-08-1(Hazardous Substances Data)

Upstream product

• 33927-05-8 methyl 3,5-dinitro-4-hydroxybenzoate 
• 124-63-0 methanesulfonyl chloride 
• 2552-45-6 methyl 4-chloro-3,5-dinitrobenzoate 
• 150-76-5 4-methoxy-phenol 

Downstream Products

• 33927-09-2 methyl 3,5-diiodo-4-(4'-methoxyphenoxy)-benzoate 
• 34043-77-1 3,5-diiodo-4-(4-methoxy-phenoxy)-benzoic acid 
• 412020-13-4 4-(4-methoxy-phenoxy)-3,5-dinitro-benzoyl chloride 
• 92061-04-6 4-(4-methoxy-phenoxy)-3,5-dinitro-benzoic acid 
• 34043-76-0 3,5-diamino-4-(4-methoxy-phenoxy)-benzoic acid methyl ester 

Relevant articles and documents

Method for inhibiting inflammatory disease

The present invention relates to methods for effectively inhibiting inflammatory diseases, such as Crohn's disease and ulcerative colitis. In other aspects, this invention relates to methods of reducing or inhibiting granulomas.

Methods for inhibiting angiogenesis

The present invention relates to methods for effectively inhibiting unwanted angiogenesis. More particularly, this invention relates to methods of treating diseases that show unwanted angiogenesis and to delivering anti-angiogenic activity to a mammal. In